Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06508658
PHASE3

A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Sponsor: Genmab

View on ClinicalTrials.gov

Summary

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). This study will assess how safe and effective epcoritamab plus lenalidomide (E-Len) is compared to rituximab plus gemcitabine and oxaliplatin (R-GemOx) )in treating adult participants with relapsed or refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL). Adverse events and change in disease condition will be assessed. Epcoritamab is an investigational drug being developed for the treatment of DLBCL. Study doctors put the participants in 1 of 3 groups, called treatment arms. Each group receives a different treatment. Around 360 adult participants with R/R DLBCL will be enrolled in approximately 165 sites across the world. Participants in arm A will receive subcutaneous (SC) injections of epcoritamab plus oral lenalidomide capsules (E-Len) for up to 12 cycles (each cycle is 28 days). Participants in arm B will receive intravenously (IV) infused R-GemOx for up to 4 cycles (each cycle is 28 days). Participants in arm C will receive SC injections of epcoritamab for up to 12 cycles (each cycle is 28 days). There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

Official title: A Phase 3, Multicenter, Randomized, Open-Label Study of Epcoritamab Plus Lenalidomide Compared to Rituximab Plus Gemcitabine and Oxaliplatin in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

379

Start Date

2024-08-13

Completion Date

2028-03

Last Updated

2026-04-08

Healthy Volunteers

No

Interventions

DRUG

Epcoritamab

Subcutaneous Injection

DRUG

Rituximab

Intravenous (IV) Infusion

DRUG

Lenalidomide

Oral Capsule

DRUG

Oxaliplatin

IV Infusion

DRUG

Gemcitabine

IV Infusion

Locations (176)

City of Hope National Medical Center /ID# 273338

Duarte, California, United States

Valkyrie Clinical Trials /ID# 269935

Los Angeles, California, United States

Desert Regional Medical Center /ID# 272437

Palm Springs, California, United States

Lutheran Medical Center- Cancer Centers of Colorado /ID# 265823

Golden, Colorado, United States

City Of Hope - Atlanta. /ID# 273092

Newnan, Georgia, United States

Rush University Medical Center /ID# 242103

Chicago, Illinois, United States

City Of Hope - Chicago /ID# 274430

Zion, Illinois, United States

Northwest Cancer Center - Dyer Clinic /ID# 269787

Dyer, Indiana, United States

Cancer Center of Kansas - Wichita /ID# 270117

Wichita, Kansas, United States

University of Kentucky Chandler Medical Center. /ID# 242087

Lexington, Kentucky, United States

University of Maryland, Baltimore /ID# 242216

Baltimore, Maryland, United States

Henry Ford Hospital /ID# 266446

Detroit, Michigan, United States

Gulfport Memorial Hospital /ID# 268104

Gulfport, Mississippi, United States

New York Medical College /ID# 265799

Valhalla, New York, United States

East Carolina University - Brody School of Medicine /ID# 242227

Greenville, North Carolina, United States

Thompson Cancer Survival Ctr /ID# 242149

Knoxville, Tennessee, United States

Community Cancer Trials Of Utah /ID# 271715

Ogden, Utah, United States

Utah Cancer Specialists - Salt Lake City /ID# 268603

Salt Lake City, Utah, United States

Veterans Affairs Medical Center - Salt Lake City /ID# 265329

Salt Lake City, Utah, United States

Hospital Universitario Austral /ID# 242791

Pilar, Buenos Aires, Argentina

Fundaleu /Id# 242789

Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina

Instituto Alexander Fleming /ID# 263804

Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina

Canberra Hospital /ID# 265312

Garran, Australian Capital Territory, Australia

Royal Prince Alfred Hospital /ID# 263242

Sydney, New South Wales, Australia

Wollongong Hospital /ID# 244646

Wollongong, New South Wales, Australia

Toowoomba Hospital /ID# 263243

Toowoomba, Queensland, Australia

Monash Health - Monash Medical Centre /ID# 262783

Clayton, Victoria, Australia

Royal Perth Hospital /ID# 243790

Perth, Western Australia, Australia

Universitair Ziekenhuis Brussel /ID# 242574

Jette, Brussels Capital, Belgium

Centre Hospitalier Epicura - Hornu /ID# 265148

Boussu, Hainaut, Belgium

Universite Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant /ID# 242565

Yvoir, Namur, Belgium

Universitair Ziekenhuis Leuven /ID# 246671

Leuven, Vlaams-Brabant, Belgium

AZ-Delta. /ID# 264740

Roeselare, West-Vlaanderen, Belgium

Hospital Sao Rafael /ID# 262949

Salvador, Estado de Bahia, Brazil

Hospital Erasto Gaertner /ID# 264049

Curitiba, Puerto Rico, Brazil

Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto /ID# 264045

Ribeirão Preto, São Paulo, Brazil

Hospital Alemao Oswaldo Cruz /ID# 247418

São Paulo, Brazil

Instituto D'Or de Pesquisa e Ensino - Regional Sao Paulo /ID# 263944

São Paulo, Brazil

Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao /ID# 242425

São Paulo, Brazil

UMHAT Sveti Georgi /ID# 242905

Plovdiv, Bulgaria

UMHAT Sveti Ivan Rilski /ID# 242389

Sofia, Bulgaria

SHAT Hematologic Diseases /ID# 242708

Sofia, Bulgaria

UMHAT Multiprofile Hospital for Active Treatment Sveta Marina /ID# 262761

Varna, Bulgaria

CIUSSS de l'est de l'Ile-de-Montreal - Hopital Maisonneuve-Rosemont /ID# 262751

Montreal, Quebec, Canada

Fundacion Arturo Lopez Perez /ID# 242421

Providencia, Santiago Metropolitan, Chile

Bradford Hill /ID# 262795

Santiago, Santiago Metropolitan, Chile

Clinica Alemana de Santiago /ID# 244139

Santiago, Chile

Peking University Third Hospital /ID# 242941

Beijing, Beijing Municipality, China

Fujian Province Cancer Hospital /ID# 265075

Fuzhou, Fujian, China

The First Affiliated Hospital of Xiamen /ID# 264305

Xiamen, Fujian, China

Sun Yat-Sen University Cancer Center /ID# 242712

Guangzhou, Guangdong, China

Guangdong Provincial Peoples Hospital /ID# 242942

Guangzhou, Guangdong, China

The Second Hospital of Hebei Medical University /ID# 242944

Shijiazhuang, Hebei, China

Harbin Medical University Cancer Hospital /Id# 242961

Harbin, Heilongjiang, China

Henan Cancer Hospital /ID# 242700

Zhengzhou, Henan, China

Union Hospital affiliated to Tongji Medical College of Huazhong University of Sc /ID# 242702

Wuhan, Hubei, China

Hubei Cancer Hospital /ID# 242963

Wuhan, Hubei, China

Jiangsu Peoples Hospital /ID# 271924

Nanjing, Jiangsu, China

The First Affiliated Hospital of Soochow University /ID# 242939

Suzhou, Jiangsu, China

The First Affiliated Hospital of Nanchang University /ID# 242703

Nanchang, Jiangxi, China

Jiangxi Provincial Cancer Hospital /ID# 242968

Nanchang, Jiangxi, China

The First Hospital of Jilin University /ID# 242940

Changchun, Jilin, China

First Affiliated Hospital of China Medical University /ID# 242701

Shenyang, Liaoning, China

Shandong Cancer Hospital /ID# 264036

Jinan, Shandong, China

Shanghai Tongji Hospital /ID# 263952

Shanghai, Shanghai Municipality, China

Tianjin Cancer Hospital /ID# 243940

Tianjin, Tianjin Municipality, China

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc /ID# 243139

Tianjin, Tianjin Municipality, China

The Affiliated Cancer Hospital of Xinjiang Medical University /ID# 242966

Ürümqi, Xinjiang, China

Yunnan Province Cancer Hospital /ID# 264057

Kunming, Yunnan, China

The First Affiliated Hospital, Zhejiang University School of Medicine /ID# 242960

Hangzhou, Zhejiang, China

Zhejiang Cancer hospital /ID# 242711

Hangzhou, Zhejiang, China

Second Affiliated Hospital, Zhejiang University - Binjiang Campus /ID# 243137

Hangzhou, Zhejiang, China

The First Affiliated Hospital of Wenzhou Medical University /ID# 263951

Wenzhou, Zhejiang, China

Klinicka bolnica Merkur /ID# 262619

Zagreb, City of Zagreb, Croatia

Klinicki bolnicki centar Sestre milosrdnice /ID# 262620

Zagreb, City of Zagreb, Croatia

Klinicki bolnicki centar Zagreb /ID# 262617

Zagreb, City of Zagreb, Croatia

Klinicki bolnicki centar Osijek /ID# 262621

Osijek, County of Osijek-Baranja, Croatia

Klinički Bolnički Centar Rijeka /ID# 266004

Rijeka, Primorje-Gorski Kotar County, Croatia

Klinicki Bolnicki Centar (KBC) Split /ID# 262618

Split, Split-Dalmatia County, Croatia

Fakultní nemocnice Hradec Králové - Sokolská /ID# 264071

Hradec Králové, Hradec Kralove, Czechia

Fakultni nemocnice Motol a Homolka /ID# 272378

Prague, Praha 5, Czechia

Fakultni nemocnice Olomouc /ID# 262832

Olomouc, Czechia

Les Hôpitaux Universitaires de Strasbourg - Hôpital de Hautepierre /ID# 264068

Strasbourg, Alsace, France

CHU de CAEN - Hopital de la Cote de Nacre /ID# 243075

Caen, Calvados, France

CHRU Tours - Hopital Bretonneau /ID# 244580

Tours, Indre-et-Loire, France

Centre Hospitalier D'Avignon /ID# 243072

Avignon, Provence-Alpes-Côte d'Azur Region, France

Centre Hospitalier de la Cote Basque /ID# 243065

Bayonne, Pyrenees-Atlantiques, France

CHU Poitiers - La miletrie /ID# 243074

Poitiers, Vienne, France

Hopital Saint Vincent de Paul /ID# 243070

Lille, France

General Hospital of Athens Laiko /ID# 262809

Athens, Attica, Greece

University General Hospital Attikon /ID# 242041

Athens, Attica, Greece

General Hospital of Athens Evaggelismos and Ophthalmiatrio of Athens Polyclinic /ID# 242039

Athens, Greece

General University Hospital of Thessaloniki AXEPA /ID# 242038

Thessaloniki, Greece

Theageneio Anticancer Hospital /ID# 242036

Thessaloniki, Greece

Pecsi Tudomanyegyetem Klinikai Kozpont /ID# 262924

Pécs, Baranya, Hungary

Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz /ID# 262901

Győr, Győr-Moson-Sopron, Hungary

Debreceni Egyetem-Klinikai Kozpont /ID# 242451

Debrecen, Hajdú-Bihar, Hungary

Szabolcs-Szatmar-Bereg Varmegyei Oktatokorhaz /ID# 242468

Nyíregyháza, Szabolcs-Szatmár-Bereg, Hungary

Semmelweis Egyetem /ID# 242455

Budapest, Hungary

Del-pesti Centrumkorhaz Orszagos Hematologiai es Infektologiai Intezet /ID# 262923

Budapest, Hungary

And 76 more locations on ClinicalTrials.gov